15 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Genomas Competitors or Alternatives

Genomas's top competitors include Esperion, Cardialen and Amarin.

Unlock 25 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Genomas's company profile

Gualberto Ruaño

President & CEO

69/100
100 - 250
$500K
$100K - 5M
  • $500K
    $100K - 5M
  • 100 - 250
    $500K
  • $100K - 5M
  • 69/100
  • 100 - 250
  • $500K
  • $100K - 5M
View ProfileView
1
Genomas's Competitor - Esperion logo

Sheldon Koenig

President & CEO

83/100
200
$845.4M
$332.3M
  • $845.4M
    $332.3M
  • 200
    $845.4M
  • $332.3M
  • 83/100
  • 200
  • $845.4M
  • $332.3M
View ProfileView
2
Genomas's Competitor - Cardialen logo

Jeff Peters

President & CEO

84/100
25 - 100
$34M
$5M - 25M
  • $34M
    $5M - 25M
  • 25 - 100
    $34M
  • $5M - 25M
  • 84/100
  • 25 - 100
  • $34M
  • $5M - 25M
View ProfileView
3
Genomas's Competitor - Amarin logo

Aaron Berg

President & CEO

82/100
275
$70M
$204.6M
  • $70M
    $204.6M
  • 275
    $70M
  • $204.6M
  • 82/100
  • 275
  • $70M
  • $204.6M
View ProfileView
4
Genomas's Competitor - Amryt Pharma logo

Joseph Wiley

Co-Founder & CEO

90/100
250 - 500
$155.8M
$100M - 500M
  • $155.8M
    $100M - 500M
  • 250 - 500
    $155.8M
  • $100M - 500M
  • 90/100
  • 250 - 500
  • $155.8M
  • $100M - 500M
View ProfileView
5
Genomas's Competitor - Regeneron logo

Leonard S. Schleifer

President & CEO

73/100
11,900
$2.1B
$14.2B
  • $2.1B
    $14.2B
  • 11,900
    $2.1B
  • $14.2B
  • 73/100
  • 11,900
  • $2.1B
  • $14.2B
View ProfileView
Genomas' top 28 competitors are Esperion, Cardialen, Amarin, Gemphire Therapeutics, Amryt Pharma, Regeneron, Kardium, The Medicines Company, CardioFocus, Sanofi, Amgen, BioVentrix, PhaseBio, CSI, AbbVie, Daiichi Sankyo, Curative Medical, PanOptica, QT Vascular, AtriCure, Trygg Pharma As, Ra Pharma, Attune, Oscor, Lilly, Sanifit, Baylis Medical and Acasti Pharma. Together they have raised over 15.0B between their estimated 238.1K employees. Genomas's revenue is the ranked 24th among it's top 10 competitors. The top 10 competitors average 7.6B. Genomas has 100 employees and is ranked 16th among it's top 10 competitors. The top 10 competitors average 8,821.

Genomas VS Esperion

Esperion has been one of Genomas's top competitors. Esperion is a Public company that was founded in 1998 in Ann Arbor, Michigan. Like Genomas, Esperion also competes in the Pharmaceuticals sector. Compared to Genomas, Esperion has 100 more employees.

Genomas VS Cardialen

Cardialen is seen as one of Genomas's biggest rivals. Cardialen is a Private company that was founded in Minneapolis, Minnesota in 2008. Like Genomas, Cardialen also operates in the Pharmaceuticals & Biotechnology sector. Cardialen has 72 fewer employees vs. Genomas.

Genomas VS Amarin

Amarin is perceived as one of Genomas's biggest rivals. Amarin was founded in Dublin, County Dublin} in 1991. Like Genomas, Amarin also competes in the Pharmaceuticals space. Compared to Genomas, Amarin generates $201.6M more revenue.

Looking for similar companies to Genomas?

Similar Companies

Pharmaceuticals companies in Greater Hartford

See 59 companies 
Companies in Hartford with employees in 100-250 range

See 100 companies 
Pharmaceuticals companies in Connecticut

See 106 companies 
Pharmaceuticals & Biotechnology companies in Greater Hartford

See 133 companies 
Pharmaceuticals & Biotechnology companies in Connecticut

See 210 companies 
Companies in Hartford with revenue in $100K-5.0M range

See 434 companies 
Pharmaceuticals companies with employees in 100-250 range

See 813 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,805 companies 
Pharmaceuticals companies with revenue in $100K-5.0M range

See 2,203 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Genomas and Genomas's Competitors

April 12, 2025StreetInsider
New York, New York--(Newsfile Corp. - April 12, 2025) - WHY:Rosen Law Firm, a global investor rights law firm, announces the filing of a class action l...
April 12, 2025PR Newswire
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the global Phase 3 DeLLphi-304 clinical trial evaluating IMDELLTRA® (tarlatamab-dlle) as a tre...
April 11, 2025Business Standard
Sanofi India announced that its managing director (MD), Rodolfo Hrosz, will step down from his role effective 30 April 2025, to take up another positio...
April 11, 2025BioPharma Dive
The bispecific antibody helped people with small cell lung cancer live longer, Amgen said. Elsewhere, J&J shared new autoimmune drug data and Alzheon r...
April 11, 2025Law 360
A Delaware federal judge on Thursday denied Amgen's bid to toss antitrust litigation brought by Regeneron accusing its rival of using a bundling scheme...
April 11, 2025Openpr
Global targeted drug delivery market is estimated to be valued at USD 10.72 Bn in 2025 and is expected to reach USD 30.88 Bn by 2032, exhibiting a comp...
April 11, 2025Openpr
Decongestant Market is estimated to be valued at USD 17.88 Bn in 2025 and is expected to reach USD 27.97 Bn in 2032, exhibiting a compound annual growt...
April 11, 2025Openpr
Calcineurin Inhibitor Market is estimated to be valued at USD 12.37 Bn in 2025 and is expected to reach USD 25.36 Bn in 2032, exhibiting a compound ann...

Frequently Asked Questions about Genomas

  1. Who are Genomas's top competitors?

    Genomas's top 3 competitors are Esperion, Cardialen, Amarin.

  2. Who is similar to Genomas?

    Esperion is the most similar to Genomas. Cardialen and Amarin are also similar to Genomas.

  1. Are Genomas and Esperion competitors?

    Yes, Esperion is one of Genomas’s top competitors.